Northern Trust’s Lipocine LPCN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$41.6K Hold
13,160
﹤0.01% 4262
2025
Q1
$41.8K Hold
13,160
﹤0.01% 4251
2024
Q4
$64.2K Hold
13,160
﹤0.01% 4229
2024
Q3
$59.1K Hold
13,160
﹤0.01% 4173
2024
Q2
$108K Buy
+13,160
New +$108K ﹤0.01% 4034
2023
Q2
Sell
-9,447
Closed -$51.1K 4568
2023
Q1
$51.1K Hold
9,447
﹤0.01% 4266
2022
Q4
$63.9K Hold
9,447
﹤0.01% 4221
2022
Q3
$72K Hold
9,447
﹤0.01% 4220
2022
Q2
$129K Sell
9,447
-449
-5% -$6.13K ﹤0.01% 4078
2022
Q1
$230K Hold
9,896
﹤0.01% 4071
2021
Q4
$167K Sell
9,896
-20
-0.2% -$338 ﹤0.01% 4258
2021
Q3
$184K Sell
9,916
-267
-3% -$4.95K ﹤0.01% 4214
2021
Q2
$242K Buy
10,183
+1,464
+17% +$34.8K ﹤0.01% 4071
2021
Q1
$224K Buy
8,719
+1,413
+19% +$36.3K ﹤0.01% 4074
2020
Q4
$169K Buy
7,306
+2,101
+40% +$48.6K ﹤0.01% 4015
2020
Q3
$125K Buy
5,205
+1,837
+55% +$44.1K ﹤0.01% 3915
2020
Q2
$72K Buy
3,368
+443
+15% +$9.47K ﹤0.01% 3983
2020
Q1
$24K Hold
2,925
﹤0.01% 4066
2019
Q4
$19K Sell
2,925
-17
-0.6% -$110 ﹤0.01% 4164
2019
Q3
$141K Sell
2,942
-47
-2% -$2.25K ﹤0.01% 3846
2019
Q2
$99K Hold
2,989
﹤0.01% 3973
2019
Q1
$117K Hold
2,989
﹤0.01% 3892
2018
Q4
$66K Sell
2,989
-12
-0.4% -$265 ﹤0.01% 3998
2018
Q3
$70K Hold
3,001
﹤0.01% 4083
2018
Q2
$66K Buy
3,001
+447
+18% +$9.83K ﹤0.01% 4080
2018
Q1
$66K Hold
2,554
﹤0.01% 4045
2017
Q4
$149K Buy
2,554
+69
+3% +$4.03K ﹤0.01% 3894
2017
Q3
$167K Buy
2,485
+678
+38% +$45.6K ﹤0.01% 3841
2017
Q2
$123K Sell
1,807
-8,570
-83% -$583K ﹤0.01% 3925
2017
Q1
$688K Sell
10,377
-317
-3% -$21K ﹤0.01% 3456
2016
Q4
$669K Sell
10,694
-54
-0.5% -$3.38K ﹤0.01% 3460
2016
Q3
$815K Sell
10,748
-58
-0.5% -$4.4K ﹤0.01% 3402
2016
Q2
$559K Buy
10,806
+8,457
+360% +$437K ﹤0.01% 3489
2016
Q1
$406K Sell
2,349
-411
-15% -$71K ﹤0.01% 3515
2015
Q4
$607K Buy
2,760
+882
+47% +$194K ﹤0.01% 3460
2015
Q3
$377K Buy
1,878
+776
+70% +$156K ﹤0.01% 3559
2015
Q2
$161K Buy
+1,102
New +$161K ﹤0.01% 3832